Literature DB >> 5773461

Ophthalmological safety of chloroquine.

S P Percival, J Behrman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5773461      PMCID： PMC1207141          DOI： 10.1136/bjo.53.2.101

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  13 in total

Review 1.  CHLOROQUINE. A REVIEW OF REACTIONS AND DERMATOLOGIC INDICATIONS.

Authors:  R B REES; H I MAIBACH
Journal:  Arch Dermatol       Date:  1963-09

2.  GLAUCOMA SURVEY IN LIBERIA.

Authors:  E NEUMANN; H ZAUBERMAN
Journal:  Am J Ophthalmol       Date:  1965-01       Impact factor: 5.258

3.  Chloroquine retinopathy; a report of eight cases with ERG and dark-adaptation findings.

Authors:  E OKUN; P GOURAS; H BERNSTEIN; L VON SALLMANN
Journal:  Arch Ophthalmol       Date:  1963-01

4.  Bilateral macular degeneration associated with chloroquine therapy.

Authors:  R PENNER; K SOMERS
Journal:  Am J Ophthalmol       Date:  1962-09       Impact factor: 5.258

5.  Some intolerances from corneal contact lenses; and a report upon high refractive error cases fitted.

Authors:  M Ruben
Journal:  Trans Ophthalmol Soc U K       Date:  1964

6.  An assessment of antimalarials in the treatment of the connective tissue diseases.

Authors:  G D Kersley
Journal:  Practitioner       Date:  1966-07

7.  Delayed onset of chloroquine retinopathy.

Authors:  R P Burns
Journal:  N Engl J Med       Date:  1966-09-29       Impact factor: 91.245

8.  Dystrophy of the macula.

Authors:  A E Braley
Journal:  Am J Ophthalmol       Date:  1966-01       Impact factor: 5.258

9.  Chloroquine retinopathy. Early detection by retinal threshold test.

Authors:  R E Carr; P Gouras; R D Gunkel
Journal:  Arch Ophthalmol       Date:  1966-02

10.  Chloroquine: ophthalmological safety, and clinical assessment in rheumatoid arthritis.

Authors:  S P Percival; I Meanock
Journal:  Br Med J       Date:  1968-09-07
View more
  9 in total

1.  Electro-ophthalmology and side-effects of drugs.

Authors:  G H Van Lith
Journal:  Doc Ophthalmol       Date:  1977-09-30       Impact factor: 2.379

2.  Drug-induced lipidoses of the cornea and conjunctiva.

Authors:  D J D'Amico; K R Kenyon
Journal:  Int Ophthalmol       Date:  1981-08       Impact factor: 2.031

Review 3.  Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates.

Authors:  Radouil Tzekov
Journal:  Doc Ophthalmol       Date:  2005-01       Impact factor: 2.379

4.  Chloroquine retinopathy: is there a safe daily dose?

Authors:  J S Marks
Journal:  Ann Rheum Dis       Date:  1982-02       Impact factor: 19.103

5.  Evaluation of hydroxychloroquine retinopathy with multifocal electroretinography.

Authors:  Scott C So; Thomas R Hedges; Joel S Schuman; Maria Luz Amaro Quireza
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2003 May-Jun

Review 6.  Remission-inducing drugs in rheumatoid arthritis.

Authors:  T P Anastassiades
Journal:  Can Med Assoc J       Date:  1980-02-23       Impact factor: 8.262

7.  Detecting chloroquine retinopathy: electro-oculogram versus colour vision.

Authors:  A S Neubauer; K Samari-Kermani; U Schaller; U Welge-Lübetaen; G Rudolph; T Berninger
Journal:  Br J Ophthalmol       Date:  2003-07       Impact factor: 4.638

Review 8.  Clinically important ocular reactions to systemic drug therapy.

Authors:  I G Rennie
Journal:  Drug Saf       Date:  1993-09       Impact factor: 5.606

9.  The eye and visual nervous system: anatomy, physiology and toxicology.

Authors:  C S McCaa
Journal:  Environ Health Perspect       Date:  1982-04       Impact factor: 9.031
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.